The following is a summary of “Improved survival in older patients with myeloid malignancies undergoing haploidentical peripheral blood stem cell transplantation with low-dose anti-thymocyte globin (ATG)/post-cyclophosphamide (PTCy)-based regimen for graft-versus-host disease prophylaxis,” published in the March 2025 issue of Annals of Hematology by Jia et al. The study analyzed haploidentical peripheral blood stem cell transplantation […]
The post Haploidentical Transplants with Low-Dose ATG and PTCy Improve Outcomes in Older Patients first appeared on Physician’s Weekly.
